Skip to main content
Clinical Trials/ACTRN12607000576426
ACTRN12607000576426
Completed
Phase 4

A randomized controlled trial of the effects of low dose zoledronic acid on bone density in osteopenic postmenopausal women

niversity of Auckland0 sites180 target enrollmentNovember 9, 2007

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Osteoporosis
Sponsor
niversity of Auckland
Enrollment
180
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 9, 2007
End Date
September 2, 2019
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
niversity of Auckland

Eligibility Criteria

Inclusion Criteria

  • Postmenopausal women
  • Bone density T Score \< \-1 and \> \-2\.5 at lumbar spine or total hip

Exclusion Criteria

  • kidney, liver, thyroid or parathyroid dysfunction
  • current cancer
  • osteoporosis
  • vitamin D deficiency
  • medications known to influence bone metabolism

Outcomes

Primary Outcomes

Not specified

Similar Trials